Porcine Reproductive and Respiratory Syndrome (PRRSV2) Viral Diversity within a Farrow-to-Wean Farm Cohort Study

Viruses. 2023 Aug 30;15(9):1837. doi: 10.3390/v15091837.

Abstract

Describing PRRSV whole-genome viral diversity data over time within the host and within-farm is crucial for a better understanding of viral evolution and its implications. A cohort study was conducted at one naïve farrow-to-wean farm reporting a PRRSV outbreak. All piglets 3-5 days of age (DOA) born to mass-exposed sows through live virus inoculation with the recently introduced wild-type virus two weeks prior were sampled and followed up at 17-19 DOA. Samples from 127 piglets were individually tested for PRRSV by RT-PCR and 100 sequences were generated using Oxford Nanopore Technologies chemistry. Female piglets had significantly higher median Ct values than males (15.5 vs. 13.7, Kruskal-Wallis p < 0.001) at 3-5 DOA. A 52.8% mortality between sampling points was found, and the odds of dying by 17-19 DOA decreased with every one unit increase in Ct values at 3-5 DOA (OR = 0.76, 95% CI 0.61-0.94, p = 0.01). Although the within-pig percent nucleotide identity was overall high (99.7%) between 3-5 DOA and 17-19 DOA samples, ORFs 4 and 5a showed much lower identities (97.26% and 98.53%, respectively). When looking solely at ORF5, 62% of the sequences were identical to the 3-5 DOA consensus. Ten and eight regions showed increased nucleotide and amino acid genetic diversity, respectively, all found throughout ORFs 2a/2b, 4, 5a/5, 6, and 7.

Keywords: genetic variation; molecular epidemiology; porcine reproductive and respiratory syndrome; whole-genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cohort Studies
  • Farms
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Nucleotides
  • Phylogeny
  • Porcine Reproductive and Respiratory Syndrome* / epidemiology
  • Porcine respiratory and reproductive syndrome virus* / genetics
  • Swine

Substances

  • Nucleotides

Grants and funding

This study was funded by Boehringer Ingelheim Vetmedica Inc., PO 6101538739; the Swine Health Information Center (SHIC) as the funding agency for MSHMP; and by the Swine Disease Eradication Center (SDEC) at the University of Minnesota.